These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10831340)

  • 41. Ovarian cancer screening.
    Sparks JM; Varner RE
    Obstet Gynecol; 1991 May; 77(5):787-92. PubMed ID: 2014097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The current status of ultrasound and color Doppler imaging in screening for ovarian cancer.
    Karlan BY; Platt LD
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S28-33. PubMed ID: 7835806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
    Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
    Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of thymidine phosphorylase in malignant ovarian tumors: correlation with microvessel density and an ultrasound-derived index of angiogenesis.
    Hata K; Nagami H; Iida K; Miyazaki K; Collins WP
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):201-6. PubMed ID: 9793193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The detection of metastases of ovarian carcinoma by immunoscintigraphy with monoclonal antibodies].
    Peking A; Marinov V
    Akush Ginekol (Sofiia); 1990; 29(1):57-60. PubMed ID: 2164792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three-dimensional ultrasonographic and power Doppler characterization of ovarian lesions.
    Kurjak A; Kupesic S; Sparac V; Kosuta D
    Ultrasound Obstet Gynecol; 2000 Sep; 16(4):365-71. PubMed ID: 11169314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Vaginal sonography: pilot study for using in ovarian screening procedures].
    Duda V; Rode G; Thein C; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):388-93. PubMed ID: 2197167
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mass-screening for ovarian cancer by transvaginal ultrasonography--study on ultrasonographic findings].
    Sato S; Sugo T; Maruyama H; Kunugi K; Saito Y; Hasuo Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1234-40. PubMed ID: 7844441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian cancer: screening, treatment, and followup.
    NIH Consens Statement; 1994 Apr 5-7; 12(3):1-30. PubMed ID: 7881476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NIH Consensus 1994: screening.
    Kramer BS; Gohagan J; Prorok PC
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S20-1. PubMed ID: 7835804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sonography of benign cystic teratoma of the ovary: pitfalls in diagnosis.
    Hertzberg BS; Kliewer MA
    AJR Am J Roentgenol; 1996 Nov; 167(5):1127-33. PubMed ID: 8911163
    [No Abstract]   [Full Text] [Related]  

  • 52. Early detection of ovarian cancer.
    Forstner R
    Eur Radiol; 2020 Oct; 30(10):5370-5373. PubMed ID: 32468105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The search for meaning-symptoms and transvaginal sonography screening for ovarian cancer: silent no more.
    Cass I
    Cancer; 2009 Aug; 115(16):3606-8. PubMed ID: 19598208
    [No Abstract]   [Full Text] [Related]  

  • 54. Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening.
    Crayford TJ; Campbell S; Bourne TH; Rawson HJ; Collins WP
    Lancet; 2000 Mar; 355(9209):1060-3. PubMed ID: 10744092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy.
    Goldberger S; Tepper R; Markov S; Beyth Y
    Obstet Gynecol; 1991 Dec; 78(6):1151-2. PubMed ID: 1945229
    [No Abstract]   [Full Text] [Related]  

  • 56. Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program.
    Schwartz PE; Chambers JT; Taylor KJ; Pellerito J; Hammers L; Cole LA; Yang-Feng TL; Smith P; Mayne ST; Makuch R
    Yale J Biol Med; 1991; 64(6):557-71. PubMed ID: 1810100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiating malignant from benign ovarian tumors with transvaginal color flow imaging.
    Peipert JF
    Obstet Gynecol; 1992 Jul; 80(1):156-7. PubMed ID: 1603488
    [No Abstract]   [Full Text] [Related]  

  • 58. Transvaginal Doppler ultrasound with color flow imaging in the diagnosis of ovarian cancer.
    Kawai M; Kano T; Kikkawa F; Maeda O; Oguchi H; Tomoda Y
    Obstet Gynecol; 1992 Feb; 79(2):163-7. PubMed ID: 1731279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
    Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
    Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Standardization of ultrasound diagnostics in gynecology.
    Gembruch U; Merz E
    Ultraschall Med; 2011 Aug; 32(4):339-41. PubMed ID: 21809235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.